A plain-language summary of every cancer trial result within a year
Every cancer trial would have to publish a short, clear summary that patients can understand, within twelve months of results, in one public place.
The EU Clinical Trials Regulation requires lay summaries within 12 months of trial end, but compliance is incomplete, quality varies and there is no US equivalent. The proposal is a global requirement (via ICMJE, registries and funders) that every interventional oncology trial deposit a plain-language summary meeting a readability standard, machine-tagged to the trial record, translated into major languages, and hosted centrally with the structured results.
- Knowledge reaches practice too slowly · Knowledge diffusion is slow: it takes years for a proven result to change what most patients receive, and no one can keep up with the literature.
- Patients lack understanding, navigation and agency · Most patients cannot understand their options, find trials, or push back, so decisions are made for them.
- Misinformation and unproven therapies · Patients are sold unproven treatments and frightened away from proven ones.
Pages like this
not linked directly; found by shared links- IdeaPublish why patients were screened out of each trial
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov.
- IdeaOne clinical trial application accepted by regulators in every major region
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov.
- IdeaA plain-language explainer for every guideline recommendation, in every major language
Shares Misinformation and unproven therapies, Patients lack understanding, navigation and agency, Knowledge reaches practice too slowly.
- IdeaTrained moderators with evidence tools in online patient communities
Shares Misinformation and unproven therapies, Patients lack understanding, navigation and agency.
- IdeaA structured pathway for patients declining proven treatment
Shares Misinformation and unproven therapies, Patients lack understanding, navigation and agency.
- IdeaOne ethics approval and one consent form for a platform trial across countries
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov.
- IdeaFund expert editors for the cancer pages of Wikipedia and Wikidata
Shares Misinformation and unproven therapies, Knowledge reaches practice too slowly.
- IdeaA verified information layer that labels and links cancer content across platforms
Shares Misinformation and unproven therapies, Knowledge reaches practice too slowly.